The present study was designed to examine the roles of p53, reactive oxygen species (ROS), and ceramide, and to determine their mutual relationships during tumor necrosis factor (TNF)-a-induced apoptosis of human glioma cells. In cells possessing wild-type p53, TNF-a stimulated ceramide formation via the activation of both neutral and acid sphingomyelinases (SMases), accompanied by superoxide anion (O 2 ÀK ) production, and induced mitochondrial depolarization and cytochrome c release, whereas p53-deficient cells were partially resistant to TNF-a and lacked O 2 ÀK generation and neutral SMase activation. Restoration of functional p53 sensitized glioma cells expressing mutant p53 to TNF-a by accumulation of O 2 ÀK . z-IETD-fmk (benzyloxycarbonyl-Ile-GluThr-Asp fluoromethyl ketone), but not z-DEVD-fmk (benzyloxycarbonyl-Asp-Glu-Val-Asp fluoromethyl ketone), blocked TNF-a-induced ceramide formation through both SMases as well as O 2 ÀK generation. Caspase-8 was processed by TNF-a regardless of p53 status of cells or the presence of antioxidants. Two separate signaling cascades, p53-mediated ROS-dependent and -independent pathways, both of which are initiated by caspase-8 activation, thus contribute to ceramide formation in TNF-a-induced apoptosis of human glioma cells.
Introduction
Cellular redox state is an important factor in determining susceptibility to different apoptotic stimuli. Reactive oxygen species (ROS), including superoxide (O 2 À K ), hydrogen peroxide (H 2 O 2 ), and hydroxyl radical ( K OH), are now recognized as signaling molecules that are mobilized in response to stimuli. Treatment of mammalian cells with tumor necrosis factor (TNF)-a triggers generation of various ROS. [1] [2] [3] [4] Antioxidants inhibit various effects of TNF-a, and the cell signaling induced by exogenous ROS is quite similar to TNF-a signaling. 5, 6 These findings support the hypothesis that ROS serve as crucial second messengers for the TNF-a signaling pathway. TNF-a has been shown to induce accumulation of p53 in various types of cells including glioma cells, suggesting the possibility of involvement of p53 in TNFa-induced cell death. [7] [8] [9] [10] Accumulating evidence suggests a role for ROS as a potential mediator of p53-dependent apoptosis. [11] [12] [13] ROS might thus play a crucial role downstream of p53 during TNF-a signaling. Currently, however, the mechanism by which cellular redox state is regulated during TNF-a-induced apoptosis and the role of ROS in modulating cell death remain unclear.
The generation of ceramide, the hydrolyzed product of the phospholipid sphingomyelin (SM), has been proposed as another mechanism participating in TNF-a-mediated apoptosis. 14 Enzymes that hydrolyze SM, such as sphingomyelinases (SMases), are regulators of intracellular ceramide levels and consequently ceramide-mediated events. These enzymes are key components of the so-called SM pathway, an ubiquitous system that functions in transducing cytokine signals to the cell interior. 15, 16 SMase is known to exist in at least two forms, neutral (N-) and acid (A-), depending on their intracellular location and pH optima. 15, 16 Although it appears that both N-and A-SMases play important roles in TNF-a signaling, 17 the molecular mechanisms by which SMases are activated and recruited during signaling are unclear. In addition, a recent study indicated that ROS participate in TNF-a-mediated ceramide formation, 18 suggesting that the ROS-sensitive pathway may be located upstream of ceramide formation. In contrast, another study demonstrated that ceramide plays a role as an intermediate in TNF-a-mediated ROS production. 3 The mutual relationship between ROS and the SM pathway during TNF-a-induced apoptosis thus remains poorly understood.
In this study, we examined the involvement of p53, ROS and ceramide in the apoptotic signaling cascade, and their mutual relationships in TNF-a-treated human glioma cells. Based on the findings obtained in this study, we propose the existence of at least two separate signaling cascades in TNFa-induced ceramide formation in human glioma cells: one is ROS dependent and the other is ROS independent. ROS generation, an upstream event in the cell death process, requires functional p53 and is dependent on the activation of caspase-8.
Results

Disruption of functional p53 by human papillomavirus type 16 (HPV-16) E6 infection inhibits TNF-a-induced apoptosis and ceramide formation
In the glioma cells tested, human recombinant TNF-a alone (up to 1 mg/ml) displayed no evidence of cytotoxity after incubation for 24 h (data not shown). However, in combination with 1 mg/ml cycloheximide (CHX), the number of apoptotic cells increased in proportion to the concentration of TNF-a (data not shown). In subsequent experiments, cells were treated with 100 ng/ml TNF-a in the presence of 1 mg/ml CHX.
Inactivation of p53 was accomplished by the expression of E6 protein of HPV-16, which binds p53 and accelerates its proteolytic degradation through the ubiquitin pathway. [19] [20] [21] Using a retroviral vector, wild-type or mutant E6 proteins and empty vector were expressed in U-87 MG human glioma cells (designated as U87-W E6, U87-M E6, and U87-LXSN, respectively), as shown previously. 22 The mutant E6 (16E6SD-8S9A10T) has substitutions of the amino acids Arg, Pro, and Arg at positions 8, 9, and 10 with the corresponding amino acids, Ser, Ala, and Thr, respectively, from the 'low-risk' type 11 HPV E6, and does not degrade p53 but performs the other known E6 functions such as activation of telomerase. 23 TNF-a caused time-dependent accumulation of p53 protein in U87-LXSN and U87-M E6 cells (Figure 1a and c). During the time course examined, however, expression of wild-type E6 protein abrogated upregulation of p53 following TNF-a treatment in U87-W E6 cells (Figure 1b) . In addition, TNF-a failed to induce p53 upregulation in U-373 MG (Figure 1d ) and U-251 MG cells (data not shown), both of which expressed mutant p53. 24 Moreover, p53 was virtually inactivated by E6 protein, as confirmed by the lack of accumulation of p53-dependent proteins such as p21 and Bax in U87-W E6, but not in U87-LXSN or U87-M E6 cells (Figure 1a-c) . Taken together, these findings proved that functional p53 of U-87 MG cells is downregulated by E6 protein expression. As shown in Figure 2a , U87-LXSN and U87-M E6 cells expressing wild-type p53 were more sensitive to TNF-a cytotoxicity than U-251 MG and U-373 MG cells possessing mutant p53. In contrast, U87-W E6 cells became partially resistant to TNF-a. These findings suggest that functional p53 plays a role in mediating TNF-a cytotoxicity.
TNF-a is known to trigger ceramide accumulation. 14 We have recently demonstrated p53-dependent ceramide formation during etoposide-induced apoptosis of human glioma cells. 22 Therefore, changes in ceramide content following TNF-a treatment were examined among cell lines with different p53 status. U87-LXSN and U87-M E6 cells expressing functional p53 exhibited significant ceramide accumulation (Figure 2b) p53-dependent N-SMase activation and p53-independent A-SMase activation during TNF-a treatment
Since N-and A-SMases are known to be involved in ceramide accumulation in response to TNF-a, 17 changes in their activities were examined. In U87-W E6 and U-251 MG cells, significant changes were observed only in A-SMase activity (four-fold increase over the control) (Figure 2c and d) . In U87-LXSN and U87-M E6 cells, TNF-a sharply increased both Figure 1 Expression of p53 and p53-dependent proteins during TNF-a treatment in human glioma cells. U87-LXSN (a), U87-M E6 (b), and U87-W E6 cell lines (c) were obtained by infecting U-87 MG cells with LXSN, LXSN-16E6SD, and LXSN-16E6SD-8S9A10T retroviruses, respectively. These cells and U-373 MG cells (d) expressing mutant p53 protein were treated with 100 ng/ ml TNF-a plus 1 mg/ml CHX for indicated periods. Cellular proteins were subjected to SDS-PAGE and immunoblotted with antibodies against p53, Bax, and p21. Data are representative of three separate experiments with compatible outcomes SMase activities at 12 h (approximately three-fold increases over the control for each). Moreover, activation of N-SMase was detectable earlier than that of A-SMase. Activation of ASMase thus appears to be independent of functional p53, whereas N-SMase activation is likely to be dependent on functional p53.
In order to determine whether ceramide generated through either A-SMase or N-SMase plays a crucial role in the apoptotic process during TNF-a treatment, the effects of specifically inhibiting N-SMase and A-SMase were examined using scyphostatin 25, 26 and ( 27, 28 respectively. As shown in Figure 3a , preincubation of human glioma cells with 1 mM scyphostatin or 10 mM SR33557 for 1 h specifically inhibited the activation of N-SMase or A-SMase induced by TNF-a, respectively, in consistent with previous reports. [25] [26] [27] [28] Throughout the inhibition of SMase activation by scyphostatin and/or SR33557, both ceramide levels and the number of apoptotic cells were significantly inhibited (Figure 3b and c) . These findings suggest that the changes in ceramide levels and activities of SMases are not consequences of the apoptotic process triggered by TNF-a. Moreover, to confirm the pathway of ceramide formation, we investigated the effect of fumonisin B1 (FB1), an inhibitor of sphinganine Nacetyltransferase, which is known to inhibit de novo synthesis of ceramide. 29, 30 FB1 at 100 mM had no effect on either TNF-ainduced accumulation of ceramide or increase in the number of apoptotic cells (Figure 3b and c). These findings indicate that ceramide is produced by SM hydrolysis, but not by de novo synthesis, during TNF-a-induced apoptosis.
p53-dependent pathway is mediated by ROS (Table 1) . Although 100 mM sodium formate failed to affect TNF-a-induced apoptosis, catalase (10 000 U/ml) and 5 mM Tiron or 1000 U/ml SOD exhibited protective effects against TNF-a-induced apoptosis in U-87 MG cells (Figure 4a) . Notably, even in the presence of effective amounts of antioxidants such as Tiron or SOD, nearly half of U-87 MG cells underwent apoptosis. These findings suggest that two separate signaling cascades are Figure 3 Effects of selective inhibitors against SMase activation. (a) U-87 MG cells were treated with 100 ng/ml TNF-a plus 1 mg/ml CHX for 12 h in the presence or absence of 1 mM scyphostatin and/or 10 mM SR33557. The activities of A-SMase and N-SMase were determined using a mixed micelle assay system with [methyl- 14 C]SM at pH 5.5 and 7.5, respectively. (b) U-87 MG cells were treated with 100 ng/ml TNF-a plus 1 mg/ml CHX for 12 h in the presence or absence of 1 mM scyphostatin, 10 mM SR33557, or 100 mM FB1. Ceramide content was measured by the E. coli diacylglycerol kinase assay. (c) U-87 MG cells were treated with 100 ng/ml TNF-a plus 1 mg/ml CHX for 24 h in the presence or absence of 1 mM scyphostatin, 10 mM SR33557, or 100 mM FB1. The cells with fragmented and condensed nuclei were counted in over 1000 cells under a fluorescent microscope. Data are means7S.D. from three independent experiments, each performed in duplicate. *Po0.05 and **P o0.01 versus TNFa alone: two-way ANOVA followed by Scheffe's post hoc test Intracellular ROS production in TNF-a-triggered human glioma cells was measured by staining these cells with ROSsensitive fluorescent dyes hydroethidium (HE) and 2 0 ,7 0 -dichlorofluorescein diacetate (DCFH-DA) 22 to confirm the effects of antioxidants. Consistent with the failure of antioxidants to inhibit TNF-a-induced apoptosis, significant increases in neither ethidium nor 2 0 ,7 0 -dichlorofluorescein (DCF) fluorescence were observed in U87-W E6 and U-251 MG cells during the time course examined (Figure 4c U87-LXSN, U87-W E6, and U-251 MG cells were treated with 100 ng/ml TNF-a plus 1 mg/ml CHX in the presence or absence of 1000 U/ml SOD or 5 mM Tiron for 24 h. *Po0.01 versus control. ** Po0.01 versus TNF-a alone.
Figure 4 ROS formation and the effects of antioxidants during TNF-a-induced apoptosis. U-87 MG cells were preincubated with 5 mM Tiron, 1000 U/ml SOD, 10 000 U/ml catalase, or 100 mM sodium formate for 24 h and then exposed to 100 ng/ml TNF-a plus 1 mg/ml CHX for 24 h. ) and U87-LXSN cells pretreated with Tiron (B,~) were exposed to 100 ng/ml TNF-a plus 1 mg/ml CHX for the indicated periods. (c and d) U87-LXSN (K), U87-W E6 (J), and U-251 MG (') cells were exposed to 100 ng/ml TNF-a plus 1 mg/ml CHX for the indicated periods. ROS production was detected with HE selective for O 2 À K or DCFH-DA (d) selective for H 2 O 2 . Data are means7S.D. from three independent experiments, each performed in duplicate Figure 5 Visualization of TNF-a-induced formation of ROS and alteration of Dc m in U-87 MG cells. U-87 MG cells were treated with 100 ng/ml TNF-a plus 1 mg/ml CHX for the indicated periods and compared with untreated control cells using a fluorescent microscopy. ROS production visualized by staining with HE (upper) or DCFH-DA (middle). Mitochondrial network visualized by staining with DiOC 6 (3) (lower). Photographs were taken with a fluorescent microscope and are representatives of at least 10 different cultures As shown in Table 1 , TNF-a-induced A-SMase activation and the resulting ceramide formation were affected by neither Tiron nor SOD in glioma cells regardless of their p53 status. In contrast, N-SMase activation in U87-LXSN cells was nearly abolished by these antioxidants. In U87-LXSN cells, the depletion of reduced glutathione (GSH) correlated well with the production of O 2 ÀK measured by the fluorescent dye HE, and pretreatment with Tiron prior to TNF-a significantly reduced GSH depletion (Figure 4b ). The addition of an O 2 ÀK -releasing agent, pyrogallol, 22, 31, 32 decreased GSH levels in U-87 MG cells, although this change was prevented to a significant extent by pretreatment with Tiron (data not shown). These results indicate that p53-mediated O 2 ÀK production is responsible for GSH depletion, leading to ceramide formation through N-SMase activation during TNF-a treatment.
Mtp53ts sensitizes cells with mutant p53 to TNF-a-induced O 2
ÀK production
The involvement of ROS in p53-mediated TNF-a-induced apoptosis was further examined in U-373 MG and U-251 MG cells transfected with an expression plasmid encoding temperature-sensitive human p53 val 138 mutant (MTp53ts), which assumes mutant conformation at 37.51C and wild-type conformation at 32.51C. 33, 34 At 32.51C, MTp53ts caused DNA fragmentation and yielded classical apoptotic morphological features through the formation of O 2 À K in U-373 MG cells, as described previously. production by TNF-a in U-373 MG cells expressing Mtp53ts and significantly prevented the cytotoxic effect of TNF-a. These findings strongly suggest that functional p53 sensitizes human glioma cells, less sensitive to TNF-a due to mutant p53, to TNF-a-induced apoptosis by a pathway that is dependent on O 2 ÀK production. Similar findings were observed for U-251 MG cells transfected with MTp53ts (data not shown).
Mitochondria are involved in both ROS-dependent and -independent signaling pathways
To examine the involvement of the mitochondrial pathway in TNF-a-mediated apoptosis, alterations of mitochondrial transmembrane potential (Dc m ) using 3,3 0 -dihexyloxacarbocyanine iodide (DiOC 6 (3)) as a fluorochrome 35, 36 as well as release of cytochrome c were examined. A sharp decrease in Dc m was detectable at 8 h following TNF-a treatment in U87-LXSN cells. The minimum level was obtained at 16 h and sustained to 24 h (Figure 7a ). Similar results were confirmed by fluorescence microscopy ( Figure 5 ). In contrast, the decrease of Dc m in U87-W E6 and U-251 MG cells was about half that seen in U87-LXSN cells (Figure 7a and b) . Moreover, antioxidants suppressed the decrease of Dc m in U87-LXSN cells to nearly the same level as in U87-W E6 cells. The involvement of mitochondria in the TNF-a-induced apoptotic pathway was further examined by determining the release of cytochrome c from mitochondria to cytosol. Cytosolic cytochrome c release was first detected at 8 h following TNF-a treatment in U87-LXSN cells (Figure 7c) . Tiron delayed the release of cytochrome c into cytosol. In U87-W E6 and U-251 MG cells, cytochrome c release in response to TNF-a was delayed and became evident at 16 h. Cytochrome c release in response to TNF-a was eliminated by benzyloxycarbonyl-Ile-Glu-Thr-Asp fluoromethyl ketone (z-IETD-fmk), a selective inhibitor for caspase-8. In contrast, benzyloxycarbonyl-Asp-Glu-Val-Asp fluoromethyl ketone (z-DEVD-fmk), a selective inhibitor for caspase-3, had no effect. Taken together, these observations suggest that mitochondria are involved in the ROS-independent signaling cascade as well as the ROS-dependent pathway downstream of caspase-8. In the TNF-a-induced cell death signaling cascade, caspase-8 appears to function as an upstream component leading to the activation of executor caspase-3 or -7. 37, 38 The processing of caspase-8 (degradation of procaspase-8 and appearance of active caspase-8) proceeded to nearly equal extents in U87-LXSN and U87-W E6 cells regardless of the p53 status (Figure 8a and b) . Antioxidants had no effects on TNF-ainduced activation of caspase-8 in U87-LXSN cells. z-IETDfmk effectively inhibited ceramide formation with abolishment of both N-and A-SMase activation (Table 2) , ROS production, and decrease in Dc m (Figure 7a and b) . On the other hand, z-DEVD-fmk had no effects on ROS production and loss of Dc m (Figure 7a and b) , although it protected cells from TNF-ainduced apoptosis (Table 2) . Caspase-8 thus functions as an apical caspase and caspase-3 as an executor caspase. Moreover, p53 accumulation in response to TNF-a treatment in U87-LXSN cells was abrogated by z-IETD-fmk, but not by z-DEVD-fmk (Figure 8c ). These results indicate that caspase-8 is upstream of p53 and p53 is located between caspase-8 and -3.
Since it has recently been reported that a lysosomal cystein protease, cathepsin B, is involved in TNF-a-induced cell death, 39, 40 we examined the effect of a specific inhibitor of cathepsin B, [L-3-trans-(propylcarbamoyl)oxirane-2-carbonyl]-L-isoleucyl-L-proline methyl ester (CA074 Me), 41 on TNF-a-induced cell death of human glioma cells. As shown in Figure 9a , 50 mM CA074 Me had no effects on TNF-ainduced apoptosis in human glioma cells. In addition, it has been reported that pretreatment with a vacuolar H þ -ATPase inhibitor, Bafilomycin A1, 42 increases lysosomal pH, resulting in the degradation of lysosomal proteinases including cathepsin B. We next investigated the effect of Bafilomycin A1, and observed that 12 h pretreatment with 10 nM Bafilomycin A1 did not affect TNF-a-induced apoptosis in human glioma cells (Figure 9a ). These results suggest that cathepsin B is not involved in TNF-a-induced apoptosis in human glioma cells.
Furthermore, it is known that cathepsin B is synthesized as a proenzyme and is transported into lysosomes where it is processed into active forms, a two-chain form (25-27 kDa) and single-chain form (29-31 kDa), by lysosomal cysteine proteinases.
42,43 Therefore, we further examined whether TNF-a can increase the amount of cathepsin B or induce the release of cathepsin B from lysosome to cytosol in human glioma cells. As shown in Figure 9b , we observed only the single-chain form of cathepsin B in whole-cell lysate of U-87 MG cells. However, this active form of cathepsin B could not be released into cytosol during TNF-a-induced cell death. Collectively, these results indicate that TNF-a-induced apoptosis is not mediated by cathepsin B in human glioma cells. U-87 MG and U-251 MG cells were treated with 100 ng/ml TNF-a plus 1 mg/ml CHX in the presence or absence of z-IETD.fmk or z-DEVD.fmk for 24 h. *Po0.01 versus control. **Po0.01 versus TNF-a alone.
TNF-a activates two distinct apoptotic cascades M Sawada et al
Depletion of functional p53 by retroviral infection of short hairpin RNA (shRNA) inhibits TNF-ainduced ceramide formation and apoptosis
Accumulation of p53 and p53-dependent proteins such as p21 and Bax during TNF-a signaling was abrogated in U-87 MG cells infected with retrovirus expressing p53 shRNA (U87-p53shRNA) compared to backbone vector (U87-vector) (Figure 10a ). These results indicate retroviral expression of p53 shRNA definitely inactivated functional p53. In agreement with the results obtained from disruption of functional p53 by HPV-16 E6 retroviral infection, we observed differences in the sensitivity to TNF-a cytotoxity between U87-vector and U87-p53shRNA cells (Figure 10b-e) . In U87-vector cells possessing wild-type p53, TNF-a stimulated ceramide formation via the activation of both N-and A-SMases, leading to apoptotic cell death. On the other hand, p53-deficient U87-p53shRNA cells were partially resistant to TNF-a and lacked ceramide formation through the activation of N-SMase but not ASMase.
Discussion
TNF-a has been shown to induce accumulation of p53 in various types of cells, suggesting the possibility of involvement of p53 in TNF-a-induced cell death. The relationship between functional p53 and susceptibility to the cytotoxic effect of TNF-a has been previously observed in ovarian cancer cells, 6 C6 rat glioma cells, 7 breast cancer cells, 8 ME-180 cells, 9 and prostatic cancer cells. 10 Consistent with these observations, our results demonstrated that disruption of functional p53 in human glioma cells by p53 shRNA as well as HPV16 E6 protein results in the decrease in the cytotoxic activity of TNF-a. However, it should be noted that even in human glioma cells devoid of functional p53, TNF-a efficiently induced apoptosis, suggesting that the p53-independent death pathway is activated by TNF-a in human glioma cells in addition to the p53-dependent one. The partial resistance of p53-deficient glioma cells to TNF-a-induced apoptosis correlated well with the amount of ceramide accumulation. It has been shown that p53-mediated apoptosis induced by genotoxic stress is accompanied by ceramide formation. 22, 44 In TNF-a-stimulated human glioma cells, the p53-mediated signaling cascade was mediated through ceramide formation Figure 8 TNF-a-triggered processing of caspase-8 in a p53-independent manner. (a) U87-LXSN cells were exposed to 100 ng/ml TNF-a plus 1 mg/ml CHX for the indicated periods in the absence or presence of 5 mM Tiron or 1000 U/ml SOD. (b) U87-W E6 cells were treated with 100 ng/ml TNF-a plus 1 mg/ml CHX for the indicated periods. Cellular proteins were subjected to SDS-PAGE and immunoblotted with antibody against caspase-8. (c) U87-LXSN cells were exposed to 100 ng/ml TNF-a plus 1 mg/ml CHX for the indicated periods in the absence or presence of 200 mM z-IETD-fmk or 200 mM z-DEVD-fmk. Cellular proteins were subjected to SDS-PAGE and immunoblotted with antibodies against p53 and b-tubulin. Data shown are representative of three separate experiments with compatible outcomes Figure 9 Cathepsin B is not involved in TNF-a-induced apoptosis in human glioma cells. (a) U-87 MG cells were treated with 100 ng/ml TNF-a plus 1 mg/ml CHX in the presence or absence of 50 mM CA074 Me and 10 nM Bafilomycin A1 for 24 h. The cells with fragmented and condensed nuclei were counted in over 1000 cells under a fluorescent microscope. Data are means7S.D. from three independent experiments, each performed in duplicate. (b) U-87 MG cells were treated with 100 ng/ml TNF-a plus 1 mg/ml CHX for the indicated periods. Wholecell lysate and cytosolic fraction were subjected to SDS-PAGE and immunoblotted with antibodies against cathepsin B and b-tubulin. Data are representative of three separate experiments with compatible outcomes by the activation of N-SMase, whereas the p53-independent pathway was associated with A-SMase.
Accumulating evidence suggests a role for ROS as mediators of p53-dependent apoptosis. [11] [12] [13] 22 TNF-a is known to induce production of ROS, which may serve as second messengers for cell death signaling. Moreover, a recent report showed that ROS participate in TNF-a-mediated ceramide generation. 18 Taken together, these findings suggest the hypothesis that p53-induced ROS production may constitute a signal for ceramide-mediated apoptosis following TNF-a treatment. Restoration of functional p53 by MTp53ts sensitized p53-deficient glioma cells to TNF-a via a pathway involving ROS production, in agreement with a previous report. 45 Of the antioxidants tested, the ability of Tiron and SOD to partially protect cells expressing functional p53 suggests that O 2 ÀK plays selective and crucial roles in TNFa-induced apoptosis. One interpretation of the partial protective effect of catalase is that hydrolysis of H 2 O 2 by catalase accelerates conversion of O 2 À K to H 2 O 2 , resulting in the reduction of O 2 ÀK level. However, it should be noted that some p53-deficient human glioma cells died even in the presence of Tiron and SOD, indicating the existence of a ROS-independent death pathway in addition to the ROS-dependent one. The latter pathway is mediated by functional p53. In wild-type p53 glioma cells, depletion of GSH correlated well with the production of O 2 À K measured using the fluorophore HE. GSH depletion was greatly reduced by the O 2 ÀK scavenger, Tiron. Therefore, O 2 À K production is responsible for GSH depletion. GSH depletion functions as an important factor in the activation of N-SMase, but does not affect the activation of A-SMase, as described previously. 18, 22, 46, 47 It thus appears that p53-mediated ROS-dependent signaling contributes to ceramide generation by N-SMase, and that the ROSindependent pathway leads to ceramide formation via ASMase. Previous studies 18, 22, 46, 47 and the present study suggest that depletion of intracellular levels of GSH is closely related to the activation of N-SMase and ceramide formation. However, a recent study demonstrated an indirect physiological effect of GSH depletion on N-SMase activation in TNF-atreated human breast cancer MCF-7 cells. 48 This finding raises the question what the mechanisms coupling oxidation/ GSH depletion to the activation of N-SMase and undetermined molecule(s) whose own oxidation may regulate NSMase are.
A recent study suggests the involvement of ceramide in TNF-a-induced ROS production. 3 In contrast, another recent study indicated that ROS participate in TNF-mediated ceramide generation.
14 In addition, direct inhibition of complex III of the mitochondrial respiratory chain by ceramide 49 and ceramide-induced cell death via disruption of mitochondrial functions 50, 51 have been demonstrated. In the present study, TNF-a-induced ceramide accumulation by N-SMase and mitochondrial changes (decrease in Dcm and cytochrome c release) were prevented by the antioxidants Tiron and SOD. Furthermore, GSH and N-acetylcysteine (NAC), which are antioxidants, inhibit the activation of N-SMase by certain apoptotic inducers. 22, 46, 47 These findings thus indicate that ceramide produced via A-SMase and N-SMase promoted mitochondrial dysfunction, and that p53-mediated ROS production is located upstream of mitochondrial changes in TNF-a-stimulated human glioma cells.
The relationship between caspases and ROS is controversial. ROS are involved in the inactivation of caspases. 52 On the other hand, caspases function as negative regulators of ROS production. 53 Most likely, caspases regulate ROS generation since inhibition of caspases results in the blockade of ROS production. 54, 55 In agreement with the latter observation, the present findings indicate that caspase-8 activation is upstream of ROS production in glioma cells with functional p53 during TNF-a-induced apoptosis. The proteolytic processing of caspase-8 was also detected in p53-deficient glioma cells. In addition, accumulation of p53 induced by TNF-a was abrogated by a selective inhibitor for caspase-8, suggesting that caspase-8 activation is located at upstream of p53. Therefore, caspase-8 may be the common initiator of p53/ ROS-dependent and -independent apoptotic pathways in TNF-a-stimulated human glioma cells. In summary, we propose a hypothetical signaling sequence ( Figure 11 ) in which mitochondria participate in TNF-ainduced apoptosis of human glioma cells by Dc m alteration and cytochrome c release through ceramide generated via p53-mediated ROS-dependent and -independent pathways, both of which are initiated by the activation of caspase-8. Considering the decreased sensitivity of p53-deficient cells to DNA-damaging agents, TNF-a may potentially be useful for the treatment of gliomas possessing mutant p53 by activating the p53-independent cell death pathway. In addition, further understanding of the SM pathway during TNF-a-induced apoptosis in human glioma cells, especially identification of direct targets of ceramide and of the biological mechanism by which ceramide induces mitochondrial dysfunction, may provide a novel approach to treatment of incurable malignant gliomas.
Materials and Methods
Materials
Human recombinant TNF-a was purchased from R&D Systems (Minneapolis, MN, USA). CHX, DiOC 6 (3), CA074 Me, and Bafilomycin A1 were from Sigma (St. Louis, MO, USA). Anticaspase-8 mouse monoclonal antibody (Ab-3), and selective caspase-8 inhibitor, z-IETDfmk, were from Calbiochem-Novabiochem (Cambridge, MA, USA). SR33557 was kindly presented by Dr. J-P Jaffrezou (Claudius Regaud Center, France). Scyphostatin was a generous gift from Dr. T Ogita (Sankyo Co. Ltd., Tokyo, Japan). Other reagents were obtained from previously noted sources. 22, 56, 57 
Cells and transfections
The human U-87 MG, U-373 MG, and U-251 MG glioblastoma cell lines were obtained from American Type Culture Collection (Rockville, MD, USA). The cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin and 100 mg/ml streptomycin in a humidified atmosphere containing 5% CO 2 at 371C. U87-LXSN, U87-W E6, and U87-M E6 cell lines were obtained by infecting U-87 MG cells with LXSN, LXSN-16E6SD, and LXSN-16E6SD-8S9A10T retroviruses, respectively. [20] [21] [22] U-373 MG and U-251 MG cells stably expressing temperature-sensitive p53 mutant, p53ts val 138 were established, as described previously. 22 To generate retrovirus vector expressing shRNA, the 3 0 LTR in a murine stem cell virus vector, pCMSCVpuro-DEST, was inactivated by an internal deletion (NheI-XbaI). 58 The self-inactivating virus vector was named Figure 11 A hypothetical scheme for TNF-a-induced signaling cascades in human glioma cells. Two separate signaling cascades, p53-induced ROS-dependent andindependent pathways, may contribute to the TNF-a-induced ceramide formation. Both pathways are initiated by caspase-8 but not mediated by caspase-3. ROSdependent and -independent pathways lead to ceramide generation via N-SMase and A-SMase, respectively. Ceramide generated through the two separate routes induces Dc m depolarization and cytochrome c release, leading to caspase-3 activation and the resultant apoptotic cell death in human glioma cells pSI-CMSCVpuro-DEST. The H1 promoter cassette with or without stuffer previously described by Brummelkamp et al. 59 was attached by attB2 and attB1 sequences by adaptor PCR (Gateway system, Invitrogen, Japan), and recombined into pDONR221 by BP reaction (Invitrogen) according to the manufacturer's instruction to generate pENTR221-H1R-stuffer or pENTR-H1R. To generate pENTR221-H1Rp53Ri, the pENTR221-H1R-stuffer was digested with BglII and HindIII and the annealed oligos (5 0 gatccccGACTCCAGTGGTAATCTACttcaagagaGTAGATTACCACTGGAGTCttttttggaaa3 0 and 5 0 agcttttccaaaaaGACTCCAGTGGTAATCTACtctcttgaaGTAGATTACCACTGGAGTCggg3 0 ) 59 were replaced with the stuffer. Both the inserts were recombined into pSI-CMSCVpuro-DEST by LR reaction (Invitrogen) according to the manufacture's instruction to generate pSI-CMSCVpuro-H1R-p53Ri and pSI-CMSCVpuro-H1R. U-87 MG cells expressing p53 shRNA and control cells were obtained by infection of SI-MSCVpuro-H1R-p53Ri and the backbone (SI-MSCVpuro-H1R) retroviruses, respectively, followed by selection with 1 mg/ml of puromycin. Comparison was performed between U-87 MG cells transduced with SI-MSCVpuro-H1R-p53Ri (designed as U87-p53shRNA) and SI-MSCVpuro-H1R (U87-vector). Prior to treatment with TNF-a, the cells were plated at a density of 5 Â 10 4 /ml and cultured for 2 days.
Nuclear staining
Apoptotic cells stained with Hoechst 33258 were quantified by fluorescent microscopic analysis. 60 Briefly, cells were fixed in 1% glutaraldehyde for 30 min. The cells were then stained with 10 mM Hoechst 33258 for 10 min. Nuclear morphology was observed under a fluorescent microscope (Olympus BX60, Tokyo, Japan).
Measurement of cellular ceramide level
Lipids extracted from cells were first treated in 0.1 M KOH in chloroform : methanol (1 : 2, v/v) at 371C for 1 h. 22, 56, 57 Ceramide was converted to ceramide 1-[ 32 P] phosphate by Escherichia coli diacylglyceol kinase in the presence of [g- 
SMase assay
The activities of both N-and A-SMases were determined using a mixed micelle assay system. 22, 56, 57 For measuring N-SMase activity, the membrane fractions (20 mg protein) were mixed with [methyl-
14 C]SM (40 000 cpm in 1 nmol of bovine brain SM in 0.25% Triton X-100 solubilized by sonication) in 0.1 M Tris/HCl buffer (pH 7.4) containing 6 mM MgCl 2 and the reaction mixture was incubated for 30 min at 371C. ASMase activity in the membrane was measured as above, except that the Tris/HCl buffer was replaced with 0.1 M sodium acetate buffer (pH 5.5) containing 5 mM EDTA.
Measurement of intracellular GSH level
Intracellular GSH content was determined according to the previously described method. 47, 56, 57 In brief, the harvested cells were suspended in 150 ml of water and 5-sulfosalicylic acid was added to a final concentration of 2%. The precipitated proteins were pelleted by centrifugation at 2000 Â g for 10 min at 41C. Aliquots of the soluble supernatant were mixed with 125 mM sodium phosphate buffer (pH 7.5) containing 6.3 mM EDTA, 0.21 mM NADPH, and 0.6 mM 5, 5-dithiobis (2-nitrobenzoic acid) in a total volume of 1 ml. On addition of glutathione reductase, the increase in absorption at 412 nm was monitored to determine the amount of GSH in the sample. A reference curve was generated with known amounts of GSH standards.
Detection of ROS and Dw m
Intracellular production of ROS was measured by using HE or DCFH-DA. O 2 ÀK is able to oxidize HE to yield ethidium and H 2 O 2 is able to oxidize DCFH to DCF. HE dissolved in DMSO or DCFH-DA dissolved in ethanol was incubated with the cells for 5 min at 371C. The final concentrations of HE and DCFH-DA were 2 and 5 mM, respectively. For the detection of Dc m , cells were incubated with 40 nM DiOC 6 (3) for 15 min at 371C. After the cells were stained, they were collected in a microcentrifuge. Intracellular ethidium, DCF, or DiOC 6 (3) fluorescence was measured by spectrofluorometer (Hitachi F-3000, Japan). In some cases, ethidium, DCF, or DiOC 6 (3) fluorescence was visualized with a fluorescent microscope (Olympus BX60, Tokyo, Japan).
Preparation of cytosolic fraction for measurement of cytochrome c release from mitochondria and of cathepsin B release from lysosmes Cytosolic extracts were prepared according to the previous report. 22 Briefly, cells were collected at the indicated times and washed twice with ice-cold PBS and resuspended in 100 ml of extraction buffer (50 mM HEPES-KOH, pH 7.4, 220 mM mannitol, 68 mM sucrose, 50 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and 1 mM E-64). After incubation on ice for 20 min, cells were homogenized with 20 strokes in a glass homogenizer with a Teflon pestle. Nuclei were removed by centrifugation at 1000 Â g for 10 min at 41C in a microcentrifuge. The resulting supernatants were clarified by centrifugation at 10 000 Â g for 15 min and further at 100 000 Â g for 60 min at 41C.
Western blot analysis
Cells were solubilized with ice-cold lysis buffer containing 1% Triton X-100, 50 mM NaCl, 25 mM HEPES (pH 7.4), 1 mM EDTA, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, and 10 mg/ml E-64. Extracted proteins (60 mg/ well) were separated by sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) on 10 or 15% polyacrylamide gels, and were electrophoretically transferred onto Immobilon-P membrane. Blocking was performed in Tris-buffered saline containing 5% skimmed milk powder and 0.1% Tween-20. The membranes were incubated with the primary antibody and then the secondary antibody coupled with horseradish peroxidase. Detection was performed with ECL system. Protein content was determined with BCA protein assay using bovine serum albumin as a standard.
Statistical analysis
Data are expressed as means7S.D. Significance was assessed by twoway ANOVA, followed by Scheffe's post hoc test. P-values less than 0.01 was considered as significant.
